Venous Thromboembolism Risk with Contemporary Lenalidomide-based Regimens Despite Thromboprophylaxis in Multiple Myeloma: A Systematic Review and Meta-analysis

TY - JOUR

T1 - Venous Thromboembolism Risk with Contemporary Lenalidomide-based Regimens Despite Thromboprophylaxis in Multiple Myeloma: A Systematic Review and Meta-analysis

AU - Mejia Garcia, Alex V.

AU - and institutional affiliations, Additional authors

N1 - Despite adequate thromboprophylaxis, lenalidomide-based regimens have a substantial risk of VTE in controlled clinical trial settings. Further studies are needed on new thromboprophylaxis strategies with regimens that have a high VTE risk.

PY - 2020

Y1 - 2020

UR - https://pubmed.ncbi.nlm.nih.gov/31913498/

M3 - Article

VL - 126

JO - Cancer

JF - Cancer

ER -